Physician profile
Eric Sherman
NPI 1073537361
$949.42
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $785 · 2020: $41.83 · 2022: $123.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $314.04 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $141.27 | 2019-2022 | |
| Sanofi Pasteur INC. | $109.41 | 2019-2020 | |
| Amarin Pharma, INC. | $84.56 | 2019 | |
| Pfizer INC. | $62.24 | 2019 | |
| Abbvie INC. | $43.14 | 2019 | |
| Lilly USA, LLC | $27.53 | 2019 | |
| Merck Sharp & Dohme LLC | $26.55 | 2019 | |
| Ferring Pharmaceuticals INC. | $25.07 | 2022 | |
| Genzyme Corporation | $20.53 | 2020 | |
| Abbott Laboratories | $20.00 | 2019 | |
| Genentech USA, INC. | $17.00 | 2019 | |
| Millicent US INC | $15.19 | 2019 | |
| Daiichi Sankyo INC. | $15.16 | 2019 | |
| Gilead Sciences, INC. | $14.81 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $12.92 | 2019 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$1,170.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Sherman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.